个人简介

华中科技大学公共卫生学院副教授，博士生导师，湖北省青年拔尖人才。2013年获华中科技大学流行病与卫生统计学博士学位；2016年被聘为华中科技大学公共卫生学院副教授；2019年9月至2021年3月赴美国哈佛大学医学院附属布列根和妇女医院开展博士后研究工作。主持华中科技大学教学改革项目，国家自然科学基金面上项目、青年项目、中国博士后科学基金面上一等资助和特别资助等项目，以通讯作者和第一作者（含共同）在Nature Genetics、Cancer Discovery、Nat Rev Clin Oncol、Oncogene和Clin Gastroenterol Hepatol等杂志发表SCI论文43篇。获湖北省自然科学奖二等奖（排名第三），华中科技大学教学竞赛二等奖和湖北省优秀博士学位论文等奖项。主要从事环境、基因与消化系统肿瘤发病风险的研究。应用多中心病例-对照研究和前瞻性队列研究，对影响消化系统肿瘤的遗传和环境病因进行了较深入的探讨，并系统整合遗传资源和环境暴露数据，试图构建基因-环境交互作用模型和肿瘤风险预测模型，为肿瘤高风险个体的筛查和个体化防治提供重要科学依据。现担任American Journal of Gastroenterology, Cancers, Molecular Carcinogenesis等杂志的审稿人。

研究方向：肿瘤流行病学；健康大数据的挖掘

主要负责的科研项目

1. 中国人群肝癌分子流行学研究，湖北省青年拔尖人才支持项目，时间：2022 -2024，经费：60万元

2. LncRNAs调控型遗传变异与中国人群肝癌易感性及机制研究，国家自然科学基金（面上项目），时间：2019 -2022，经费：58万元

3. 基于大数据的肿瘤风险预测模型在前瞻性队列人群中的验证研究， 国家重点研发计划“重大慢性非传染性疾病防控研究”专项子课题，时间：2016 -2020，分拨经费：10万元

4. FOXA1先锋转录因子靶基因结合区遗传变异与乳腺癌易感性的关系及机制研究，国家自然科学基金（青年项目），时间：2015 -2017，经费：23万元

5. 叉头框A蛋白靶基因结合区遗传变异与肝癌易感性研究，中国博士后科学基金会，时间：2013-2015，经费：8万元

6. 乙肝病毒受体分子遗传多态与HBV易感性的研究，经费来源：中国博士后科学基金会，时间：2014-2016，经费：15万元

7. TGF-β信号通路关键基因低频遗传变异与结直肠癌易感性研究，经费来源：华中科技大学自主创新研究基金，时间：2015-2016，经费：5万元

代表性论著

(^†co-first author, *Corresponding author)

1. Gurjao C^†, Zhong R^†, Haruki K^†, Li Y, Spurr, L, Spurr H, et al. Discovery and features of an alkylating signature in colorectal cancer. Cancer Discovery. 2021; 11(10):2446-2455. (^†co-first author)

2. Chang J^†, Zhong R^†, Tian J^†, Li J^†, Zhai K, Ke J, Lou J, Chen W, Zhu B, Shen N, Zhang Y, Zhu Y, Gong Y, Yang Y, Zou D, Peng X, Zhang Z, Zhang X, Huang K, Wu T, Wu C*, Miao X*, Lin D. Exome-wide analyses identify low-frequency variant in CYP26B1 and additional coding variants associated with esophageal squamous cell carcinoma. Nat Genet. 2018; 50(3):338-343,. (^†co-first author)

3. Zhong R, Tian J, Fu M, Ma S, Liu L, Li J et al. LINC01149 variant modulates MICA expression that facilitates hepatitis B virus spontaneous recovery but increases hepatocellular carcinoma risk. Oncogene. 2020; 39(9):1944-1956.

4. Wang H^†, Yang B^†, Cai X, Cheng X, Shen N, Liu L, Li J, Wang Y, He H, Ying P, Li B, Lu Z, Yang N, Wang X, Zhang F, Li Y, Wang W, Ning C, Zhu Y, Chang J, Miao X, Tian J*, Zhong R*. Hepatocellular carcinoma risk variant modulates lncRNA HLA-DQB1-AS1 expression via a long-range enhancer-promoter interaction. Carcinogenesis. 2021;42(11):1347-1356. (*Corresponding author)

5. He H, Deng Y, Wan H, Shen N, Li J, Zeng Q, Chang J, Lu Q, Miao X, Tian J*, Zhong R*. Urinary bisphenol A and its interaction with CYP17A1 rs743572 are associated with breast cancer risk. Chemosphere. 2022;286(Pt 3):131880. (*Corresponding author)

6. Jin W, Jiang G, Yang Y, Yang J, Yang W, Wang D, Niu X, Zhong R*, Zhang Z*, Gong J*. Animal-eRNAdb: a comprehensive animal enhancer RNA database. Nucleic acids research. 2022;50(D1):D46-D53. (*Corresponding author)

7. Li B, Cheng X, Zhu Y, Wan H, Lu Z, Cai Y, Li W, Yi P, Liu L, Chang J, Miao X, Tian J*, Zhong R*. FOXA1 of regulatory variant associated with risk of breast cancer through allele-specific enhancer in the Chinese population. Breast cancer. 2022;29(2): 247-259.

8. Zhong R^†, He H^†, Jin M^†, Lu Z, Deng Y, Liu C, Shen N, Li J, Wang H, Ying P, Li B, Zeng Q, Lu Q, Cheng L, Zhu Y, Miao X, Tian J. Genome-wide gene-bisphenol A, F and triclosan interaction analyses on urinary oxidative stress markers. The Science of the total environment. 2022;807(Pt 1):150753. (^†co-first author)

9. Akimoto N^†, Ugai T^†, Zhong R^†, Hamada T, Fujiyoshi K, Giannakis M, Wu K, et al. Rising incidence of early-onset colorectal cancer - a call to action. Nat Rev Clin Oncol. 2021; 18(4):230-243. (^†co-first author)

10. Deng Y, He H, Wan H, Shen N, Li J, Zhang S, Zeng Q, Chang J, Lu Q, Zhong R*, Miao X. Bisphenol A exposure, interaction with genetic variants and colorectal cancer via mediating oxidative stress biomarkers. Environ Pollut. 2021; 287:117630. (*Corresponding author)

11. Ugai T^†, Haruki K^†, Vayrynen JP^†, Zhong R^†, Borowsky J, Fujiyoshi K, Lau MC, et al. Coffee Intake and Colorectal Cancer Incidence According to T-Cell Response. JNCI Cancer Spectr. 2020; 4(6):pkaa068,. (^†co-first author)

12. Akimoto N^†, Zhao M^†, Ugai T^†, Zhong R^†, Hamada T, Fujiyoshi K, Giannakis M, Wu K, et al. Tumor long interspersed nucleotide element-1 (LINE-1) hypomethylation in relation to age at diagnosis of colorectal cancer. Cancers. 2021; 13(9):2016. (^†co-first author)

13. Deng Y, Wan H, Tian J, Cheng X, Rao M, Li J, Zhang H, Zhang M, Cai Y, Lu Z,.Li Y, Niu S, Shen N, Chang J, Fang Z*, Zhong R*. CpG-methylation-based risk score predicts progression in colorectal cancer. Epigenomics. 2020; 12(7):605-615. (*Corresponding author)

14. Gong Y^†, Hu N^†, Ma L, Li W, Cheng X, Zhang Y, Zhu Y, Yang Y, Peng X, Zou D, Tian J, Yang L, Mei S, Wang X, Lo C. H., Chang J, Hou T, Zhang H, Xu B, Zhong R*, Yuan P*. ABTB2 Regulatory Variant as Predictor of Epirubicin-Based Neoadjuvant Chemotherapy in Luminal A Breast Cancer. Front Oncol. 2020; 10:571517. (*Corresponding author)

15. Shen N, Wang P, Li Y, Zhu Y, Gong Y, Zhong R*, Lu Y*, Cheng L*. Nonreceptor protein tyrosine phosphatases (NRPTPs) gene family associates with the risk of hepatocellular carcinoma in a Chinese hepatitis B virus-related subjects. Mol Carcinog. 2020; 59(8):980-988. (*Corresponding author)

16. Cheng X, Wang Y, Tian J, Zhou L, Chen X, Guo H, Zeng J, Shen N, Li J, Ke J, Zhu Y, Gong J, Chang J, Liu L*, Zhong R*. SLC10A1 S267F variant influences susceptibility to HBV infection and reduces cholesterol level by impairing bile acid uptake. J Viral Hepat. 2019; 26(10):1178-1185. (*Corresponding author)

17. Zhu B, Zhu Y, Tian J, Shen N, Li J, Lou J, Ke J, Yang Y, Gong Y, Gong J, Chang J, Miao X*, Zhong R*. A functional variant rs1537373 in 9p21.3 region is associated with pancreatic cancer risk. Mol Carcinog. 2019; 58(5):760-766. (*Corresponding author)

18. Wang S, Xiang C, Mou L, Yang Y, Zhong R*, Wang L et al. Trans-acting nonsynonymous variant of FOXA1 predisposes to hepatocellular carcinoma through modulating FOXA1-ERalpha transcriptional program and may have undergone natural selection. Carcinogenesis.2020; 41(2):146-158. (*Corresponding author)

19. Shen N^†, Li L^†, Xu W, Tian J, Yang Y, Zhu Y, Gong Y, Ke J, Gong J, Chang J, Zhong R*, Miao X*. A missense variant in PTPN12 associated with the risk of colorectal cancer by modifying Ras/MEK/ERK signaling. Cancer Epidemiol.2019; 59: 109-114. (*Corresponding author)

20. Gong Y, Cheng X, Tian J, Li J, Zhu Y, Yang Y, Zou D,Peng X, Luo J, Zhao L, Mei S, Wang X, Yang L, Ke J, Gong J, Chang J, Wang Y*, Zhong R*. Integrative analysis identifies genetic variant modulating MICA expression and altering susceptibility to persistent HBV infection. Liver International. 2019; 39(10):1927-1936. (*Corresponding author)

21. Zhang Y^†, Yang B^†, Cheng X, Liu L, Zhu Y, Gong Y, Yang Y, Tian J, Peng X, Zou D, Yang L, Mei S, Wang X, Lou J, Ke J, Li J, Gong J, Chang J, Yuan P*, Zhong R*. Integrative functional genomics identifies regulatory genetic variant modulating RAB31expression and altering susceptibility to breast cancer. Mol Carcinog. 2018; 57(12): 1845-1854. (*Corresponding author)

22. Chang J^†, Tian J^†, Zhu Y^†, Zhong R^†, Zhai K, Li J, Ke J, Han Q, Lou J, Chen W, Zhu B, Shen N, Zhang Y, Gong Y, Yang Y, Zou D, Peng X, Zhang Z, Zhang X, Huang K, Yang M, Wang L, Wu C*, Lin D*, Miao X*. Exome-wide analysis identifies three low-frequency missense variants associated with pancreatic cancer risk in Chinese populations. Nat Commun. 2018; 9(1), 3688. (^†co-first author)

23. Chang J^†, Tian J^†, Yang Y^†, Zhong R^†, Li J, Zhai K, Ke J, Lou J, Chen W, Zhu B, Shen N, Zhang Y, Gong Y, Zhu Y, Zou D, Peng X, Huang K, Miao X*. A rare missense variant in TCF7L2 associates with colorectal cancer risk by interacting with a GWAS-identified regulatory variant in the MYC enhancer. Cancer Res. 2018; 78(17): 5164-5172. (^†co-first author)

24. Li J, Wang Y, Zhu Y, Gong Y, Yang Y, Tian J, Zhang Y, Zou D, Peng X, Ke J, Gong J, Zhong R*, Chang J*. Breast cancer risk-associated variants at 6q25.1 influence risk of hepatocellular carcinoma in a Chinese population. Carcinogenesis.2017; 38(4):447-454. (*Corresponding author)

25. Zhang Y, Li Y, Jiang S, Chen W, Lou J, Ke J, Li J, Zhu Y, Gong Y, Yang Y, Tian J, Peng X, Zou D, Gong J, Chang J, Miao X*, Zhong R*. A functional variant rs4442975 modulating FOXA1-binding affinity does not influence the risk or progression of breast cancer in Chinese Han population. Oncotarget. 2016; 7(49): 81691-81697. (*Corresponding author)

26. Chen X, Wu F, Liu Y, Lou J, Zhu B, Zou L, Chen W, Gong J, Wang Y*, Zhong R*. The contribution of serum hepatitis B virus load in the carcinogenesis and prognosis of hepatocellular carcinoma: evidence from two meta-analyses. Oncotarget. 2016; 7(31): 49299-49309. (*Corresponding author)

27. Chen X, Wang Y, Cheng K, Li J, Lou J, Ke J, Yang Y, Gong Y, Zhu Y, Wang L*, Zhong R*. Genetic variants in the regulatory region of SLC10A1 are not associated with the risk of hepatitis B virus infection and clearance. Infection, Genetics and Evolution. 2016; 44: 495-500. (*Corresponding author)

28. Liu C^†, Zhong R^†, Lou J, Pan A, Tang Y, Chang J, Ke J, Li J, Yuan J, Wang Y, Chen W, Guo H, Wei S, Liang Y, Zhang X, He M, Hu FB, Wu T, Yao P, Miao X (2016) Nighttime sleep duration and risk of nonalcoholic fatty liver disease: the Dongfeng-Tongji prospective study. Annals of Medicine. 2016; 48(6): 468-476. (^†Co-first authors)

29. Zhong R, Liu L, Zou L, Sheng W, Zhu B, Xiang H, Chen W, Chen J, Rui R, Zheng X, Yin J, Duan S, Yang B, Sun J, Lou J, Xie D, Xu Y, Nie S*, Miao X*. Genetic variations in the TGFbeta signaling pathway, smoking and risk of colorectal cancer in a Chinese population. Carcinogenesis. 2013; 34(4), 936-942.

30. Zhong R, Chen X, Zhu B, Lou J, Li J, Shen N, Yang Y, Gong Y, Zhu Y, Yuan J, Xia X*, Miao X*. MAD1L1 Arg558His and MAD2L1 Leu84Met interaction with smoking increase the risk of colorectal cancer. Sci Rep. 2015; 5:12202.

31. Zhu B, Zou L, Qi L, Zhong R*, Miao X*. Allium Vegetables and Garlic Supplements do Not Reduce Risk of Colorectal Cancer, Based on Meta-analysis of Prospective Studies. Clin Gastroenterol Hepatol. 2014; 12(12), 1991-2001. (*Corresponding author)

32. Zhong R, Liu L, Tian Y, Wang Y, Tian J, Zhu B, Chen W, Qian J, Zou L, Xiao M, Shen N, Yang H, Lou J, Qiu Q, Ke J, Lu X, Wang Z, Song W, Zhang T, Li H, Wang L*, Miao X*. Genetic variant in SWI/SNF complexes influences hepatocellular carcinoma risk: a new clue for the contribution of chromatin remodeling in carcinogenesis. Sci Rep. 2014; 4, 4147.

33. Zhong R, Liu L, Zou L, Zhu Y, Chen W, Zhu B, Shen N, Rui R, Long L, Ke J, Lu X, Zhang T, Zhang Y, Wang Z, Sun Y, Cheng L, Miao X*. Genetic variations in TERT-CLPTM1L locus are associated with risk of lung cancer in Chinese population. Mol Carcinog. 2013; 52 Suppl 1, E118-126.

34. Zhong R, Yang B, Tang H, Zou L, Song R, Zhu L*, Miao X*. Meta-analysis of the association between DCDC2 polymorphisms and risk of dyslexia. Mol Neurobiol. 2013; 47(1), 435-442.

35. Zhong R^†, Tian Y^†, Liu L^†, Qiu Q, Wang Y, Rui R, Yang B, Duan S Y, Shi J, Miao X*, Wang L*, Li H. HBV-related hepatocellular carcinoma susceptibility gene KIF1B is not associated with development of chronic hepatitis B. PLoS One. 2012; 7(2), e28839.

36. Chen W^†, Song H^†, Zhong R^†, Zhu B, Guo H, Lou J, Shen N, Li J, Chen X, Liu C, Ming J, Huang T*, Miao X*. Risk of GWAS-identified genetic variants for breast cancer in a Chinese population: A multiple interaction analysis. Breast Cancer Res Treat. 2013;142(3), 637-644. (^†Co-first authors)

37. Li J, Zou L, Chen W, Zhu B, Shen N, Ke J, Lou J, Song R, Zhong R*, Miao X*. Dietary mushroom intake may reduce the risk of breast cancer: evidence from a meta-analysis of observational studies. PLoS One. 2014;9: e93437. (*Corresponding author)

38. Zhang X^†, Zhong R^†, Zhang Z, Yuan J, Liu L, Wang Y, Kadlubar S, Feng F, Miao X*. Interaction of cyclooxygenase-2 promoter polymorphisms with helicobacter pylori infection and risk of gastric cancer. Mol Carcinog. 2011; 50(11), 876-883. (^†Co-first authors)

39. Zhang X^†, Zhong R^†, Liu L^†, Wang Y, Yuan J, Wang P, Sun C, Zhang Z, Song W, Miao X*. Smoking and cox-2 functional polymorphisms interact to increase the risk of gastric cardia adenocarcinoma in chinese population. PLoS One. 2011; 6(7), e21894. (^†Co-first authors)

40. Liu L^†, Zhong R^†, Zou L, Fu J, Zhu B, Chen W, Ye X, Gao Y, Yang Y, Christiani D. C. Chen S, Miao X. Variants in the 5'-upstream region of GPC5 confer risk of lung cancer in never smokers. Cancer Epidemiol. 2014; 38(1):66-72. (^†Co-first authors)

41. Yang J^†, Duan S^†, Zhong R^†, Yin J, Pu J, Ke J, Lu X, Zou L, Zhang H, Zhu Z, Wang D, Xiao H, Guo A, Xia J, Miao X*, Tang S*, Wang G*. Exome sequencing identified nrg3 as a novel susceptible gene of hirschsprung's disease in a Chinese population. Mol Neurobiol. 2013; 47(3), 957-966. (^†Co-first authors)

42. Liu L^†, Wu J^†, Zhong R^†, Wu C, Zou L, Yang B, Chen W, Zhu B, Duan S, Yu D, Tan W, Nie S*, Lin D*, Miao X*. Multi-loci analysis reveals the importance of genetic variations in sensitivity of platinum-based chemotherapy in non-small-cell lung cancer. Mol Carcinog. 2013; 52(12), 923-931. (^†Co-first authors)

43. Han W^†, Zhou Y^†, Zhong R^†, Wu C, Song R, Liu L, Zou L, Qiao Y, Zhai K, Chang J, Huang L, Lu X, Lou J, Yu D, Tan W, Zhang J, Wang H*, Miao X*. Functional polymorphisms in fas/fasl system increase the risk of neuroblastoma in chinese population. PLoS One. 2013; 8(8), e71656. (^†Co-first authors)

44. 陈伟, 张怡, 朱颖, 杨洋, 龚雅洁, 缪小平, 钟荣. p53靶基因结合区遗传变异与中国人群乳腺癌遗传易感性的关联研究. 中华流行病学杂志, 2016; 37(8): 1063-1068.（通讯作者）

45. 陈雪琴, 王英, 娄娇, 杨洋, 龚雅洁, 朱颖, 向成, 钟荣. MicroRNA-122结合区遗传变异IL-1A rs3783553与慢性HBV感染的关联研究. 华中科技大学学报(医学版) 2016:53-55+69.（通讯作者）